ATXI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ATXI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Avenue Therapeutics's insider ownership is 4.21%.
Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Avenue Therapeutics's Institutional Ownership is 12.31%.
Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Avenue Therapeutics's Float Percentage Of Total Shares Outstanding is 93.25%.
The historical data trend for Avenue Therapeutics's Insider Ownership can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avenue Therapeutics Historical Data
The historical data trend for Avenue Therapeutics can be seen below:
2023-06-30 | 2023-07-31 | 2023-08-31 | 2023-09-30 | 2023-10-31 | 2023-11-30 | 2023-12-31 | 2024-01-31 | 2024-02-29 | 2024-03-31 | |
Insider Ownership | 20.15 | 20.15 | 19.50 | 20.81 | 20.81 | 14.08 | 14.08 | 5.00 | 5.00 | 4.21 |
The percentage of shares that are owned by company insiders relative to the total shares outstanding.
Neil Herskowitz | director | 2109 BROADWAY, SUITE 206, NEW YORK NY 10023 |
Jay D Kranzler | director | 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO CA 92121 |
Rosenwald Lindsay A Md | director | 375 PARK AVE, NEW YORK NY 10152 |
Fortress Biotech, Inc. | 10 percent owner | 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS FL 33154 |
Invagen Pharmaceuticals, Inc. | 10 percent owner | SITE B, 7 OSER AVE., HAUPPAUGE NY 11788 |
Alexandra Maclean | officer: Chief Executive Officer | C/O AVENUE THERAPEUTICS, INC., 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK NC 10014 |
Faith L. Charles | director | ABEONA THERAPEUTICS INC., 1330 AVENUE OF THE AMERICAS - FLOOR 33, NEW YORK NY 10019 |
David Jin | officer: Int. PEO, Int. PFO, and COO | C/O AVENUE THERAPEUTICS, INC., 1140 AVENUE OF THE AMERICAS, FLOOR 9, NEW YORK NY 10036 |
Joseph Walter Vazzano | officer: Chief Financial Officer | 1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK NY 10019 |
Curtis Gale Oltmans | director | C/O ARRAY BIOPHARMA INC., 3200 WALNUT ST., BOULDER CO 80301 |
Lucy Lu | director, officer: President, CEO | THE FEMALE HEALTH COMPANY, 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Elizabeth Garrett Ingram | director | 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362 |
Thomas Gregory Moore | director | C/O AKORN, INC., 1925 WEST FIELD COURT, SUITE 300, LAKE FOREST IL 60045 |
Nishant Saxena | director | CIPLA HOUSE, PENINSULA BUSINESS PARK, LOWER PAREL, MUMBAI K7 400013 |
Jaideep Ashok Gogtay | director | CIPLA LTD., MUMBA CENTRAL, BESIDE CITY CENTER, MUMBAI K7 400008 |
From GuruFocus
By Marketwired • 05-16-2024
By Marketwired • 04-29-2024
By Marketwired • 10-31-2023
By Value_Insider Value_Insider • 11-10-2022
By sperokesalga sperokesalga • 03-02-2023
By Marketwired • 08-10-2023
By Stock market mentor Stock market mentor • 01-27-2023
By sperokesalga sperokesalga • 04-27-2023
By Marketwired • 08-09-2024
By PRNewswire PRNewswire • 01-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.